RICT 2018

CALL FOR ABSTRACTS

Deadline: May 15, 2018

Register and Submit your abstract

Conferences > Upcoming events > RICT 2018

Confirmed Speakers


Plenary Speakers

Chemical Biology on the Genome
Prof. Shankar BALASUBRAMANIANProf. Shankar BALASUBRAMANIAN
(UNIVERSITY OF CAMBRIDGE, Cambridge, United Kingdom)

Read more
Nanoparticle-based Strategies in Oncology
Prof. Jean-Pierre BENOITProf. Jean-Pierre BENOIT
(UNIVERSITY OF ANGERS, Angers, France)

Read more
Two Adventures in Chemical Biology - in vivo chemistry and real-time optical medical imaging.
Prof. Mark BRADLEYProf. Mark BRADLEY
(UNIVERSITY OF EDINBURGH, Edinburgh, United Kingdom)

Read more
Disrupting Cancer Care & Outcomes by Putting Patients in the Driving Seat
Dr Anne BRUINVELSDr Anne BRUINVELS
(PX HEALTHCARE, London, United Kingdom)

Read more
PROTAC-mediated Protein Degradation: A New Therapeutic Modality
Prof. Craig CREWSProf. Craig CREWS
(UNIVERSITY OF YALE, New Haven, United States)

Read more
Ghrelin Receptor Ligands: from the Bench to the Drug!
Dr Jean-Alain FEHRENTZDr Jean-Alain FEHRENTZ
(CNRS-UNIVERSITY OF MONTPELLIER, Montpellier, France)

Read more
Decoy Chemokine Ligands Targeting CXCL12, CCL17 and CCL22: Discovery and Anti-inflammatory Activity
Dr Jean-Luc GALZIDr Jean-Luc GALZI
(CNRS-UNIVERSITY OF STRASBOURG, Illkirch, France)

Read more
Ancient and Modern Scaffolds for Biologically Active Chemical Space
Prof. Arasu GANESANProf. Arasu GANESAN
(UNIVERSITY OF EAST ANGLIA, Norwich, United Kingdom)

Read more
Structure-guided Development of Selective GPCR Ligands
Prof. Peter GMEINERProf. Peter GMEINER
(FRIEDRICH ALEXANDER UNIVERSITY, Erlangen, Germany)

Read more
Title to be announced
Title to be announced
Dr Alexander HEIFETZDr Alexander HEIFETZ
(EVOTEC, Abingdon, United Kingdom)
Structure-Based Drug Discovery for G Protein-Coupled Purine Receptors
Prof. Kenneth A. JACOBSONProf. Kenneth A. JACOBSON
(NIDDK, Bethesda, United States)

Read more
Chemical Tools to Probe Reversible Lysine Acetylation
Prof. Manfred JUNGProf. Manfred JUNG
(ALBERT LUDWIGS UNIVERSITY OF FREIBURG, Freiburg, Germany)

Read more
Pharmacophore-based Analysis of Molecular Dynamics Trajectories: Towards Understanding KD of Protein Ligands
Prof. Thierry LANGERProf. Thierry LANGER
(UNIVERSITY OF VIENNA, Vienna, Austria)

Read more
Potential Therapeutic Targets in the Brain Renin-Agiotensin and Apelinergic Systems for Treatment of Cardiovascular Diseases
Dr Catherine  LLORENS-CORTESDr Catherine LLORENS-CORTES
(INSERM-COLLÈGE DE FRANCE, Paris, France)

Read more
Chemistry as the Helping Tool to Develop New Therapeutic Strategies
Prof. Maria Luz LOPEZ-RODRIGUEZProf. Maria Luz LOPEZ-RODRIGUEZ
(COMPLUTENSE UNIVERSITY OF MADRID, Madrid, Spain)

Read more
The Confobody technology, a New Platform to Enable Fragment Screening on GPCRs
Dr Christel MENETDr Christel MENET
(CONFO THERAPEUTICS, Brussels, Belgium)

Read more
Novel Modes of Chemical Regulation of GPCRs
Prof. Graeme MILLIGANProf. Graeme MILLIGAN
(UNIVERSITY OF GLASGOW, Glasgow, United Kingdom)

Read more
Single Electron Processes Enabling Organic Synthesis
Prof. Gary A. MOLANDERProf. Gary A. MOLANDER
(UNIVERSITY OF PENNSYLVANIA, Philadelphia, United States)

Read more
Discovery of Foliglurax, an mGluR4 PAM for the Treatment of Parkinson’s Disease.
Dr Stephan SCHANNDr Stephan SCHANN
(DOMAIN THERAPEUTICS SA, Illkirch, France)

Read more
Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism
Dr Patrick SCHNIDERDr Patrick SCHNIDER
(ROCHE PHARMACEUTICAL, Basel, Switzerland)

Read more
Therapeutic In Vivo Synthetic Chemistry
Prof. Nori TANAKAProf. Nori TANAKA
(RIKEN, Saitama, Japan)

Read more
Cellular Delivery and Oral Uptake of Cyclic Peptides
Dr Thomas  VORHERRDr Thomas VORHERR
(NOVARTIS, Basel, Switzerland)

Read more

Keynote Speakers

Topical Intestinal Agonists of the Bile Acid Receptor TGR5: Controlling Target Engagement by Innovative Molecular Engineering
Dr Julie CHARTONDr Julie CHARTON
(UNIVERSITY OF LILLE, INSTITUT PASTEUR DE LILLE, Lille, France)

Read more
Drug-target Residence Time – a Misleading Concept
Dr Rutger FOLMERDr Rutger FOLMER
(MERCACHEM, Nijmegen, The Netherlands)

Read more
Inducible Chemical-genetic Fluorescent Markers for Bioimaging
Dr Arnaud GAUTIERDr Arnaud GAUTIER
(ECOLE NORMALE SUPÉRIEURE, Paris, France)

Read more
Discovery of New Brain Penetrating Neuropeptide S Receptor (Npsr) Antagonists
Dr Julien POTHIERDr Julien POTHIER
(IDORSIA PHARMACEUTICALS LTD., Allschwil, Switzerland)

Read more
Discovery of The Clinical Candidate Ribuvaptan, a Dual Acting Vasopressin V1a/V2 Receptor Antagonist for the Treatment of Heart Failure
Dr Carsten SCHMECKDr Carsten SCHMECK
(BAYER, Wuppertal, Germany)

Read more
Dye-loaded Lipid Nanoparticles: Contrast Agents for Image-guided Surgery and Tools for Drug Delivery
Dr Isabelle TEXIERDr Isabelle TEXIER
(LETI-HEALTH, Grenoble, France)

Read more

Organised by

EFMC Sponsored Event

Supported by

Media Partners

Copyright 2018 LD Organisation  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 10 454777  |   |  VAT: BE 0464819842
Developed and powered by Antalys